February 24, 2023 the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules.
The proposed rules – developed with the U.S. Department of Health and Human Services and in close coordination with the U.S. Department of Veterans Affairs – propose to extend many of the flexibilities adopted during the public health emergency with appropriate safeguards.
Diego Dominguez’ trail to becoming an Oklahoma State University Scholar in Urban Medicine and a third-year medical student started years ago when he was just 12 years old on his first visit to a doctor after moving from El Salvador to his new home in the United States. That visit did not go well.
“I couldn’t explain my symptoms in a different language and unlike the other patients at the clinic I didn’t have anyone to translate for me,” Dominguez recalls.
But now, doctors will have to take substance use disorder training to get their DEA license. The Biden administration’s recent spending bill contained under-the-radar changes for addiction medicine, including eliminating the X waiver requirement for clinicians who treat opioid use disorder with medication-assisted treatment (MAT).
Since the start of the COVID pandemic in 2020, we have seen the introduction of new regulations that apply to healthcare entities — and a relaxing of others. While some COVID-era changes may permanently remain in place, such as rules related to telemedicine, others are temporary or may have already ended. Healthcare providers need to be alert for temporary changes that are coming to an end and need to also confirm that they have properly understood any waivers or changes in the law on which they previously relied.
Hard thresholds for pain medication doses and duration are no longer promoted through the CDC’s new Clinical Practice Guideline for Prescribing Opioids for Pain. The new guidance — which covers acute, subacute, and chronic pain for primary care and other clinicians — updates and replaces the controversial 2016 CDC opioid guideline for chronic pain.
Abortion Guidelines for Oklahoma osteopathic physicians were approved by the State Board of Osteopathic Examiners at its September 15, 2022, Special Board Meeting.
The number of doctors of osteopathic medicine (DOs) is enjoying a significant growth pattern. This year alone, 7300 osteopathic physicians are entering the workforce, and they make up more than 25% of the medical student population. The pipeline of future DOs is at an all-time high of 36,500 students, according to the American Osteopathic Association (AOA).
During a September 2021 interview on The Tonight Show with Jimmy Fallon, comedian Hasan Minhaj referred to doctors of osteopathic medicine, or DOs, as “off-brand doctors” compared with their MD counterparts. The medical community — MDs and DOs alike — hit back.
News from the AOA:
The AOA is pleased to share the American Osteopathic Association’s 2022 Osteopathic Medical Profession (OMP) Report. The report updates yearly progress toward the advancement of the osteopathic profession within the AOA and the broader medical community.